A review of life science current events reported by MedCity News this week:
Medtronic CEO Bill Hawkins will postpone retirement. So now the question is: What to make of Medtronic CEO Bill Hawkins’ decision to postpone his retirement?
Kendle acquired by INC Research in $232 million CRO deal. And now, the Kendle acquisition gives INC Research greater scale. Now the company needs to make the case that it can provide an attractive strategic partnership alternative to Quintiles, Covance and PPD. The company’s ability to do so will determine whether INC reaches its goal of becoming a top five CRO in five years or instead remains just outside of that top tier.
Is the healthcare industry really buying into the medical mart concept Going back to those innocent and optimistic days of 2009 when the three-city medical mart competition was just taking shape, one thing has always been clear: For any of the projects to succeed, the healthcare industry would have to buy into the untested medical mart concept. That is to say, the success of any medical mart would clearly be dependent on hospital purchasing managers seeing value in visiting a single location with a wide array of vendors peddling their wares to the hospital industry.
PPD is top global CRO in CenterWatch survey; N.C. CROs take 4 of top 10 spots. PPD, based in Wilmington, North Carolina, is the top-rated global clinical research organization in the 2011 CenterWatch Global Investigative Site Survey. The results are based on survey responses from clinical research site professionals in more than 70 global locations. PPD led all CROs receiving responses of “excellent” or “good” on 84 percent of survey responses.